Functional Medicine
These endorphins are able to either help boost the immune system where it is low, like in cancers or HIV; or it modulates the immune system where it is hyperreactive like in autoimmune conditions and gut issues. This means that the body now has enough of the right kind of ‘soldiers’ to target and solve health issues using its own innate intelligence. Because this is all done by your own endorphins, LDN is extremely safe. LDN has been used for a wide range of health concerns in patients with autoimmune diseases, cancers, HIV, MS, SLE, Crohn’s and ulcerative colitis, amongst others.
Date: 6:30pm 3rd July 2025
Cost: Free
We take a look at Low Dose Naltrexone (LDN) and explore its promising results for medical management of complex conditions that have typically been difficult to treat, including Chronic Fatigue Syndrome (CFS/ME), Multiple Sclerosis (MS), and long COVID.
Explore how LDN could help you in our live webinar, hosted by Dr Harpal Bains, founder and medical director of Harpal Clinic.
Ask questions and get a complimentary 10-minute 1-2-1 mini consultation with Dr Bains.
“The turnaround with LDN has been nothing short of miraculous, and a real game changer. After 4 months, the turnaround has been dramatic. I can sleep for 9 - 11 hours, of good quality sleep (8 out of 10), and things are improving at a faster rate. Energy levels are higher, brain fog has lifted, and most dramatic of all, my mood has improved 100%. I no longer feel depressed, despite being suboptimal. I wake up happier, relaxed, and with a positive mindset, excited about the future. The key to LDN was definitely perseverance. Each stage caused initial upset, and then the reward phase followed. The big pay off being 4 months down the line. Definitely worth the wait. Without the help of Dr Bains and Harpal Clinic, I would not have made this breakthrough.”
— P.C
We can provide Low Dose Naltrexone (LDN) as an adjunct to your current management by your doctors. Please assume a minimum of 3 months of being on LDN before you start to notice a difference if any, although in the majority of people, this can be much sooner.
Whilst this is not strictly necessary, we prefer to work with your main doctors as LDN is still in its infancy.
Whilst this is not strictly necessary, we prefer to work alongside your main doctors. This is because, although naltrexone is a very well established and safe drug, its use in very low doses is considered off-label and so many doctors are not familiar with it. Being able to share your progress with your GP may help educate them and inspire them to guide others better in similar situations.
LDN is available in various forms:
Step 1 – Initial medical consultation (£195)
Before we can prescribe LDN, a one-off, standalone 30-minute medical consultation is required. This allows our doctor to assess your full medical history, discuss your symptoms and goals, and determine if LDN is an appropriate and safe option for you.
This includes:
Please note: This non-refundable fee covers your doctor’s time, expertise and guidance. It applies whether or not you proceed with our LDN monthly membership.
Step 2 – Optional LDN membership (£72.50/month)
If you’re a good candidate for treatment, we will invite you to join our monthly LDN membership programme.
This includes:
Looking to explore your health more deeply?
We offer advanced consultation pathways that allow you to explore wider health concerns beyond LDN. Your doctor can advise if this might be appropriate for you. Your initial medical consultation fee can be credited towards this, should you choose to continue your care with us.
To join, email us at help@harpalclinic.co.uk or complete our Book An Appointment form.
Dr Harpal Bains is a huge supporter of the LDN Research Trust. She has been lecturing internationally to spread her experience and expertise in prescribing LDN within her practice, particularly in conjunction with her knowledge of combining it with patients who have concurrent hormonal imbalances, adrenal fatigue and multi-system disorders. Her talks can be viewed here:
Inflammaging in MS patients – study conclusion one year later (2024)
Behcet’s Disease – Could this novel approach be the answer? (2022)
How to increase patient compliance when side effects just seem too much (2022)
Managing Hashimoto’s: Are We Asking the Right Questions in Hypothyroidism? (2018)
You can also listen to Dr Harpal Bains speaking on the LDN Radio Show here:
Dr Harpal Bains on the LDN Radio Show 2020
Dr Harpal Bains talks about Low Dose Naltrexone and her new clinic 2019